Response Evaluation Using 68 Ga-DOTA-IBA in a Case of Metastatic Prostate Cancer.

IF 9.6 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Clinical Nuclear Medicine Pub Date : 2025-06-01 Epub Date: 2025-01-23 DOI:10.1097/RLU.0000000000005666

Linwei Li, Yue Chen

引用次数: 0

Abstract

Abstract: We report a case of a patient with metastatic prostate cancer receiving first-line endocrine therapy. Clinical symptoms, PSA level, and CT confirmed the significant progression of his bone metastatic lesions. In comparison to images at baseline, follow-up bone scan incorrectly showed remission of the bone lesions, whereas follow-up 68 Ga-DOTA-IBA correctly showed disease progression.

查看原文本刊更多论文

68Ga-DOTA-IBA治疗1例转移性前列腺癌疗效评价

摘要：我们报告一例转移性前列腺癌患者接受一线内分泌治疗。临床症状、PSA水平和CT证实其骨转移性病变进展明显。与基线图像相比，随访骨扫描错误地显示骨病变缓解，而随访68Ga-DOTA-IBA正确显示疾病进展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Nuclear Medicine 医学-核医学

CiteScore

2.90

自引率

31.10%

发文量

1113

审稿时长

2 months

期刊介绍： Clinical Nuclear Medicine is a comprehensive and current resource for professionals in the field of nuclear medicine. It caters to both generalists and specialists, offering valuable insights on how to effectively apply nuclear medicine techniques in various clinical scenarios. With a focus on timely dissemination of information, this journal covers the latest developments that impact all aspects of the specialty. Geared towards practitioners, Clinical Nuclear Medicine is the ultimate practice-oriented publication in the field of nuclear imaging. Its informative articles are complemented by numerous illustrations that demonstrate how physicians can seamlessly integrate the knowledge gained into their everyday practice.